Clinical Trials for Overland Therapeutics

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Overland Therapeutics

Clinical Trials (2)

A Study of OL-CD19-GDT in Relapsed/ Refractory Autoimmune Diseases

PHASE1Recruiting

44 participants

Started: Oct 31, 2025 · Completed: Dec 31, 2028

2 conditions2 sponsors1 location

A Study of OL-101 Injection in Patients with Relapsed or Refractory Multiple Myeloma (RRMM)

PHASE1Recruiting

58 participants

Started: Oct 23, 2024 · Completed: Oct 31, 2028

1 condition2 sponsors3 locations